BRIEF-Arch Biopartners' AB569 receives positive opinion from EMA COMP

* Arch biopartners' AB569 receives positive opinion from EMA COMP for orphan designation for cystic fibrosis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.